- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IMPEDIMED Aktie jetzt für 0€ handeln | |||||
| 02.10. | IMPEDIMED LIMITED: Notice of Initial Substantial Holder | - | ASX | ||
| 30.09. | IMPEDIMED LIMITED: Change of Director's Interest Notice - Mr Erik Anderson | - | ASX | ||
| 24.09. | IMPEDIMED LIMITED: Update on Options | 1 | ASX | ||
| 11.09. | IMPEDIMED LIMITED: Date of 2026 Annual General Meeting | - | ASX | ||
| 27.08. | ImpediMed Ltd Full Year Sales Increase | 1 | RTTNews | ||
| 27.08. | IMPEDIMED LIMITED: 2026 Annual Report | 1 | ASX | ||
| 27.08. | IMPEDIMED LIMITED: Appendix 4G and Corporate Governance Statement | 3 | ASX | ||
| 27.08. | IMPEDIMED LIMITED: Appendix 4E | 1 | ASX | ||
| 19.08. | IMPEDIMED LIMITED: FDA Clearance for Sarcopenia Risk Assessment Received | - | ASX | ||
| 13.08. | IMPEDIMED LIMITED: ASX Listing Rule 7.16 Compliance | 2 | ASX | ||
| 06.08. | IMPEDIMED LIMITED: Notification of cessation of securities - IPD | - | ASX | ||
| 28.07. | ImpediMed Q4 FY26 slides: mixed results despite improved cash position | 1 | Investing.com | ||
| 28.07. | ImpediMed Q4 FY26 slides: cash improves, execution lags targets | 1 | Investing.com | ||
| 27.07. | IMPEDIMED LIMITED: Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr | - | ASX | ||
| 27.07. | IMPEDIMED LIMITED: Investor Presentation | - | ASX | ||
| 23.07. | IMPEDIMED LIMITED: Notification of Q4 FY26 Quarterly Results Investor Webinar | - | ASX | ||
| 20.07. | IMPEDIMED LIMITED: Notification of cessation of securities - IPD | - | ASX | ||
| 03.07. | IMPEDIMED LIMITED: Change of Director's Interest Notice - Mr Andrew Grant | - | ASX | ||
| 03.07. | IMPEDIMED LIMITED: Change of Director's Interest Notice - Ms Emmanuel-Donnelly | - | ASX | ||
| 03.07. | IMPEDIMED LIMITED: Change of Director's Interest Notice - Ms Janelle Delaney | - | ASX |
1 2 3 4 Weiter >>
65 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| FRESENIUS | 42,485 | +2,15 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,450 | +1,99 % | Fresenius Medical Care: Helen Giza verlässt den Konzern - Nachfolger steht fest | Bad Marienberg (www.anleihencheck.de) - Ad hoc-Mitteilung der Fresenius Medical Care AG vom 07.10.2026:Der Aufsichtsrat der Fresenius Medical Care AG hat heute einstimmig beschlossen, Shervin J. Korangy... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BETA BIONICS | 17,440 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| NEUROPACE | 12,390 | 0,00 % | KeyBanc initiates NeuroPace stock coverage with overweight rating |
Das Unternehmen IMPEDIMED LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +40,00 % bei einem Aktienkurs von 0,004 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMPEDIMED LIMITED finden Sie auf Wallstreet Online.